ETH Cycle Returns: From $1,422 to $4,865 and the Harsh Reality of Timing

Ethereum has always been a story of cycles, but rarely does the data make the point so bluntly. A multi-year chart now circulating among analysts maps three defining price levels: the 2018 reference zone near $1,422, the 2021 peak around $4,865, and today’s range close to $2,078. For anyone tracking ETH across market phases, the gap between those numbers tells a story that no amount of long-term optimism can smooth over.

How $1,422 vs. $4,865 Entry Points Created Two Completely Different Stories

The chart makes one thing immediately clear: entry point is everything. Investors who accumulated during the 2018 cycle have weathered volatility and still sit on meaningful gains. Those who bought near the 2021 peak at $4,865 remain deeply underwater at current levels Ethereum On-Chain Levels Show 4 Key Price Zones to Watch reinforces this, identifying realized price and investor cost-basis bands as the key zones still defining sentiment and resistance across this cycle.

ETH’s current structure reflects a prolonged consolidation after two failed attempts to reclaim previous highs. The pattern is not linear growth – it is a series of sharp expansions followed by extended drawdowns, each phase resetting expectations for a fresh pool of participants.

ETH at $2,078: Key Support Levels That Now Define the Next Move

Losing structural levels has accelerated that downside in the current cycle. As covered in ETH Drops Below $2,800 Support as Price Tests $2,650, each broken support level shifts momentum toward deeper zones and changes the short-term outlook considerably. The broader framework discussed in Ethereum Price Analysis: Will $3,900 Support Hold? shows how quickly key levels become ceilings once broken.

What the multi-year chart ultimately captures is a cycle-driven asset still searching for directional clarity. At $2,078, Ethereum sits between its historic peaks and the lows that defined earlier accumulation windows – a position that offers opportunity for patient entrants but little comfort for those still holding from the 2021 top.